Stemline Therapeutics, Inc.
Clinical trials sponsored by Stemline Therapeutics, Inc., explained in plain language.
-
New drug cocktails aim to stall metastatic breast cancer
Disease control OngoingThis study tests a drug called elacestrant combined with other medicines in people with a common type of advanced breast cancer (ER+/HER2-). The goal is to find safe doses and see if these combinations can slow down cancer growth. About 435 adults with metastatic breast cancer wi…
Phase: PHASE1, PHASE2 • Sponsor: Stemline Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New pill shows promise for advanced breast cancer in early trial
Disease control OngoingThis Phase 2 trial tests the drug elacestrant in 61 people with estrogen receptor-positive, HER2-negative metastatic breast cancer who have not previously used CDK4/6 inhibitors. Participants take a daily pill for about 6 months. The study aims to see if the drug can delay cancer…
Phase: PHASE2 • Sponsor: Stemline Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC